Commonly used heart drug may up cardiac arrest risk
Sudden cardiac arrest is lethal in minutes if untreated
Author
Lilly’s combo therapy succeeds in late-stage lung cancer study
Previously untreated patients with metastatic non-small cell lung cancer taking a combination of Lilly’s Cyramza and Roche’s…
FDA approves generic valsartan amid drug shortage
The FDA said it had sped up the review of the generic from India’s Alkem Laboratories before its approval
Sun Pharma raises stake in Russia’s PJSC Biosintez to 96.96 pc
The company's wholly-owned subsidiary, Sun Pharma (Netherlands) BV, has increased its shareholding in PJSC Biosintez by way of…
Glenmark gets USFDA nod for generic version of acne treatment gel
The approval is for Clindamycin and Benzoyl Peroxide Gel, one per cent/five per cent, a generic version of BenzaClin1 Gel, one per…
LTE appoints India and South-East Asia exports manager
Kolkata-based Ashim Chakravarty, who has 20 years of professional experience in the life sciences industry, has been given the…
USFDA issues import alert on Hospira’s Chennai plant
The alert was imposed after the regulator found lapses with regard to good manufacturing practice (CGMP) regulations
Zydus Cadila gets USFDA nod to market generic anti-diabetic drug
The company has received tentative approval from USFDA to market Sitagliptin and Metformin Hydrochloride extended-release tablets…
SC asks ex-Ranbaxy promoters to apprise how they’ll comply with Rs 3500 cr arbitral award
The bench headed by Chief Justice Ranjan Gogoi has asked the Singh brothers who promoted the pharmaceutical company, to appear…
Lupin responds to US FDA’s OAI letter
Lupin is in the process of sending further updates of its corrective actions to the US FDA and remains hopeful of a positive…